Pneumococcal vaccine conjugate 11-valent (GlaxoSmithKline)

N/A

Report date: 2023/04/25 13:58:56

Base Information

Drug NamePneumococcal vaccine conjugate 11-valent (GlaxoSmithKline)

Drug Alias Name11Pn-PD11-Pn-CVGSK 513026Pneumococcal 11-valent vaccine conjugate - GlaxoSmithKline11 Pn-PD vaccine +[6]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis AStreptococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBelgiumSlovakia +[5]

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsHepatitis AStreptococcal Infections

Other Information

ATC CodeN/A